- Išsiųsime per 10–14 d.d.
/images/books/2820378/9780128184806.jpg)
- Leidėjas: Academic Press
- ISBN-10: 0128184809
- ISBN-13: 9780128184806
- Formatas: 19.1 x 23.5 x 2.2 cm, minkšti viršeliai
- Kalba: Anglų
- Extra -15 % nuolaida šiai knygai su kodu: ENG15
Drug Discovery Targeting Drug-Resistant Bacteria (el. knyga) (skaityta knyga) | knygos.lt
Atsiliepimai
Aprašymas
Drug Discovery Targeting Drug-Resistant Bacteria explores the status and possible future of developments in fighting drug-resistant bacteria. The book covers the majority of microbial diseases and the drugs targeting them. In addition, it discusses the potential targeting strategies and innovative approaches to address drug resistance. It brings together academic and industrial experts working on discovering and developing drugs targeting drug-resistant (DR) bacterial pathogens. New drugs active against drug-resistant pathogens are discussed, along with new strategies being used to discover molecules acting via new modes of action. In addition, alternative therapies such as peptides and phages are included.
Pharmaceutical scientists, microbiologists, medical professionals, pathologists, researchers in the field of drug discovery, infectious diseases and microbial drug discovery both in academia and in industrial settings will find this book helpful.
EXTRA 15 % nuolaida su kodu: ENG15
Akcija baigiasi už 5d.22:02:33
Nuolaidos kodas galioja perkant nuo 10 €. Nuolaidos nesumuojamos.
- Leidėjas: Academic Press
- ISBN-10: 0128184809
- ISBN-13: 9780128184806
- Formatas: 19.1 x 23.5 x 2.2 cm, minkšti viršeliai
- Kalba: Anglų
Drug Discovery Targeting Drug-Resistant Bacteria explores the status and possible future of developments in fighting drug-resistant bacteria. The book covers the majority of microbial diseases and the drugs targeting them. In addition, it discusses the potential targeting strategies and innovative approaches to address drug resistance. It brings together academic and industrial experts working on discovering and developing drugs targeting drug-resistant (DR) bacterial pathogens. New drugs active against drug-resistant pathogens are discussed, along with new strategies being used to discover molecules acting via new modes of action. In addition, alternative therapies such as peptides and phages are included.
Pharmaceutical scientists, microbiologists, medical professionals, pathologists, researchers in the field of drug discovery, infectious diseases and microbial drug discovery both in academia and in industrial settings will find this book helpful.
Atsiliepimai